Literature DB >> 17638807

Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases.

Seza A Gulec1, Yuman Fong.   

Abstract

OBJECTIVE: To discuss the basic concepts involved in the development of yttrium 90 (Y-90) microsphere selective internal radiation treatment and review the clinical data pertaining to its application in hepatic colorectal cancer metastases. DATA SOURCES: Published studies and scientific paper presentations. STUDY SELECTION: Randomized clinical studies and retrospective reviews.
CONCLUSIONS: Selective internal radiation treatment is a promising new modality in the treatment of patients with hepatic colorectal cancer metastases as part of a multimodality approach. A chemo-selective internal radiation treatment neoadjuvant approach has a potential to improve therapeutic outcomes. Clinical studies in neoadjuvant and salvage settings are needed for more concrete outcome data and design of optimal multimodality treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638807     DOI: 10.1001/archsurg.142.7.675

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  19 in total

Review 1.  Controlling radiation exposure during interventional procedures in childhood cancer patients.

Authors:  John M Racadio
Journal:  Pediatr Radiol       Date:  2008-12-16

Review 2.  Advances in image-guided intratumoral drug delivery techniques.

Authors:  Luis Solorio; Ravi B Patel; Hanping Wu; Tianyi Krupka; Agata A Exner
Journal:  Ther Deliv       Date:  2010-08

3.  Portal vein embolisation for extended hepatectomy: single-centre experience.

Authors:  Soumil Vyas; Clare Bent; Stefano Partelli; Ajit T Abraham; Robert R Hutchins; Satyajit Bhattacharya; Deborah Low; Tim Fotheringham; Hemant M Kocher
Journal:  J Gastrointest Cancer       Date:  2012-09

Review 4.  Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: an institutional experience and review of the literature.

Authors:  Steven Naymagon; Richard R P Warner; Kalpesh Patel; Noam Harpaz; Josef Machac; Joshua L Weintraub; Michelle K Kim
Journal:  Dig Dis Sci       Date:  2010-03-03       Impact factor: 3.199

Review 5.  Pathology of non-Helicobacter pylori gastritis: extending the histopathologic horizons.

Authors:  Gregory Y Lauwers; Hiroshi Fujita; Koji Nagata; Michio Shimizu
Journal:  J Gastroenterol       Date:  2009-12-05       Impact factor: 7.527

6.  Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis.

Authors:  M A D Vente; M Wondergem; I van der Tweel; M A A J van den Bosch; B A Zonnenberg; M G E H Lam; A D van Het Schip; J F W Nijsen
Journal:  Eur Radiol       Date:  2008-11-07       Impact factor: 5.315

Review 7.  Update and review of the multidisciplinary management of stage IV colorectal cancer with liver metastases.

Authors:  Sherif Raafat Zikry Abdel-Misih; Carl R Schmidt; Paul Mark Bloomston
Journal:  World J Surg Oncol       Date:  2009-09-29       Impact factor: 2.754

8.  Neutron activation of holmium poly(L-lactic acid) microspheres for hepatic arterial radio-embolization: a validation study.

Authors:  M A D Vente; J F W Nijsen; R de Roos; M J van Steenbergen; C N J Kaaijk; M J J Koster-Ammerlaan; P F A de Leege; W E Hennink; A D van Het Schip; G C Krijger
Journal:  Biomed Microdevices       Date:  2009-08       Impact factor: 2.838

9.  Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model.

Authors:  M A D Vente; T C de Wit; M A A J van den Bosch; W Bult; P R Seevinck; B A Zonnenberg; H W A M de Jong; G C Krijger; C J G Bakker; A D van het Schip; J F W Nijsen
Journal:  Eur Radiol       Date:  2009-09-30       Impact factor: 5.315

10.  Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections.

Authors:  Seza A Gulec; Kenneth Pennington; Michael Hall; Yuman Fong
Journal:  World J Surg Oncol       Date:  2009-01-08       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.